Clinical studies have identified high expression levels of TBK1 in the tumor tissues of stage 1 non-small cell lung cancer (NSCLC) patients that were significantly correlated with poor prognosis [122]. This evidence concerns the gene TBK1 and non-small cell lung carcinoma.